Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC (R)-citalopram oxalate | 219861-53-7 | MFCD06407825 | 99.5% | 414.43 | C22H23FN2O5 | 5 MG
SDP

Catalog No. 5000263590
Encompass_Preferred

(R)-Citalopram oxalate is the R-enantiomer of the antidepressant citalopram, supplied as the oxalate salt for research use. It is reported to be substantially less potent than the S-enantiomer and is used in enantiomer-specific pharmacology, serotonin transporter binding, and structure-activity relationship studies.

  • R-enantiomer of citalopram, supplied as the oxalate salt.
  • High purity, 99.5%.
  • Molecular weight 414.43 g/mol.
  • Chemical formula C22H23FN2O5.
  • Intended for research applications, including transporter binding and SAR studies.
  • Available in small research pack sizes (e.g., 5 mg).

Catalog No. 50-002-63590 Supplier Medchemexpress LLC Supplier No. HY1102895MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

(R)-Citalopram oxalate is the R-enantiomer of the antidepressant citalopram, supplied as the oxalate salt for research use. It is reported to be substantially less potent than the S-enantiomer and is used in enantiomer-specific pharmacology, serotonin transporter binding, and structure-activity relationship studies.

  • R-enantiomer of citalopram, supplied as the oxalate salt.
  • High purity, 99.5%.
  • Molecular weight 414.43 g/mol.
  • Chemical formula C22H23FN2O5.
  • Intended for research applications, including transporter binding and SAR studies.
  • Available in small research pack sizes (e.g., 5 mg).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.